Artwork

Inhalt bereitgestellt von Uppsala Monitoring Centre. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Uppsala Monitoring Centre oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!

#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

42:45
 
Teilen
 

Manage episode 442753974 series 2749727
Inhalt bereitgestellt von Uppsala Monitoring Centre. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Uppsala Monitoring Centre oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Disproportionality analyses are a mainstay of pharmacovigilance research, but without clear guidelines, they often lead to confusion and misinterpretation. Enter the READUS-PV statement: the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible.

Tune in to find out:

  • The history of reporting guidelines in pharmacovigilance and why the READUS-PV guidelines were created
  • Why there has been a spike in the publication of disproportionality analyses in recent years and what this means for their reliability
  • What it means to publish “good” pharmacovigilance science

Want to know more?

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.

  continue reading

Kapitel

1. #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori (00:00:00)

2. Intro (00:00:11)

3. Welcome (00:01:26)

4. What is disproportionality analysis? (00:01:57)

5. A reporting problem in PV science (00:03:58)

6. What is the READUS-PV project? (00:09:49)

7. Why the recent spike in disproportionality reporting? (00:15:06)

8. Effects of the reporting spike (00:18:34)

9. Enhancing Pharmacovigilance Reporting Practices (00:19:44)

10. What has prevented a more widespread support of previous guidelines? (00:21:27)

11. Patterns in the publication of disproportionality analyses (00:22:40)

12. What is the Delphi method? (00:24:20)

13. Transparency, replicability and reproducibility in PV research - what impact will the READUS-PV have? (00:31:59)

14. Implementing Pharmacovigilance Reporting Guidelines (00:36:10)

15. What are the next steps to ensure uptake and integration of READUS-PV into the community? (00:36:30)

16. Listener question: How does READUS-PV apply to disproportionality analyses on medication errors? (00:37:39)

17. Final comments (00:39:20)

18. Outro (00:41:32)

52 Episoden

Artwork
iconTeilen
 
Manage episode 442753974 series 2749727
Inhalt bereitgestellt von Uppsala Monitoring Centre. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Uppsala Monitoring Centre oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

Disproportionality analyses are a mainstay of pharmacovigilance research, but without clear guidelines, they often lead to confusion and misinterpretation. Enter the READUS-PV statement: the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible.

Tune in to find out:

  • The history of reporting guidelines in pharmacovigilance and why the READUS-PV guidelines were created
  • Why there has been a spike in the publication of disproportionality analyses in recent years and what this means for their reliability
  • What it means to publish “good” pharmacovigilance science

Want to know more?

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.

  continue reading

Kapitel

1. #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori (00:00:00)

2. Intro (00:00:11)

3. Welcome (00:01:26)

4. What is disproportionality analysis? (00:01:57)

5. A reporting problem in PV science (00:03:58)

6. What is the READUS-PV project? (00:09:49)

7. Why the recent spike in disproportionality reporting? (00:15:06)

8. Effects of the reporting spike (00:18:34)

9. Enhancing Pharmacovigilance Reporting Practices (00:19:44)

10. What has prevented a more widespread support of previous guidelines? (00:21:27)

11. Patterns in the publication of disproportionality analyses (00:22:40)

12. What is the Delphi method? (00:24:20)

13. Transparency, replicability and reproducibility in PV research - what impact will the READUS-PV have? (00:31:59)

14. Implementing Pharmacovigilance Reporting Guidelines (00:36:10)

15. What are the next steps to ensure uptake and integration of READUS-PV into the community? (00:36:30)

16. Listener question: How does READUS-PV apply to disproportionality analyses on medication errors? (00:37:39)

17. Final comments (00:39:20)

18. Outro (00:41:32)

52 Episoden

Alle Folgen

×
 
Loading …

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

 

Kurzanleitung

Hören Sie sich diese Show an, während Sie die Gegend erkunden
Abspielen